Defining therapeutic benefit for people with schizophrenia: Focus on negative symptoms
Authors:
- 1 March 2015
- journal article
- review article
- Published by Elsevier in Schizophrenia Research
- Vol. 162 (1-3) , 169-174
Abstract
No abstract availableKeywords
This publication has 49 references indexed in Scilit:
- Pharmacological approaches to treating negative symptoms: A review of clinical trialsSchizophrenia Research, 2013
- Quantifying Clinical Relevance in the Treatment of SchizophreniaClinical Therapeutics, 2011
- Prevalence of Negative Symptoms in Outpatients With Schizophrenia Spectrum Disorders Treated With Antipsychotics in Routine Clinical PracticeThe Journal of Clinical Psychiatry, 2009
- The Burden of Schizophrenia on CaregiversPharmacoEconomics, 2008
- Persistent Negative Symptoms in Schizophrenia: An OverviewSchizophrenia Bulletin, 2007
- Pharmacological treatment of negative symptoms of schizophrenia: therapeutic opportunity or Cul‐de‐sac?Acta Psychiatrica Scandinavica, 2007
- Remission in Schizophrenia: Proposed Criteria and Rationale for ConsensusAmerican Journal of Psychiatry, 2005
- Statistical Significance and Clinical RelevanceArchives of Dermatology, 2004
- Genetic and physiological data implicating the new human gene G72 and the gene for d -amino acid oxidase in schizophreniaProceedings of the National Academy of Sciences, 2002
- The Scale for the Assessment of Negative Symptoms (SANS): Conceptual and Theoretical FoundationsThe British Journal of Psychiatry, 1989